IBDEI0TX ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14772,1,4,0)
 ;;=4^338.22
 ;;^UTILITY(U,$J,358.3,14772,1,5,0)
 ;;=5^Chronic Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,14772,2)
 ;;=^334075
 ;;^UTILITY(U,$J,358.3,14773,0)
 ;;=338.28^^90^866^28
 ;;^UTILITY(U,$J,358.3,14773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14773,1,4,0)
 ;;=4^338.28
 ;;^UTILITY(U,$J,358.3,14773,1,5,0)
 ;;=5^Other Chronic Postop Pain
 ;;^UTILITY(U,$J,358.3,14773,2)
 ;;=^334076
 ;;^UTILITY(U,$J,358.3,14774,0)
 ;;=338.29^^90^866^27
 ;;^UTILITY(U,$J,358.3,14774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14774,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,14774,1,5,0)
 ;;=5^Other Chronic Pain
 ;;^UTILITY(U,$J,358.3,14774,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,14775,0)
 ;;=338.3^^90^866^8
 ;;^UTILITY(U,$J,358.3,14775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14775,1,4,0)
 ;;=4^338.3
 ;;^UTILITY(U,$J,358.3,14775,1,5,0)
 ;;=5^Cancer Associated Pain
 ;;^UTILITY(U,$J,358.3,14775,2)
 ;;=^334078
 ;;^UTILITY(U,$J,358.3,14776,0)
 ;;=338.4^^90^866^11
 ;;^UTILITY(U,$J,358.3,14776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14776,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,14776,1,5,0)
 ;;=5^Chronic Pain Syndrome
 ;;^UTILITY(U,$J,358.3,14776,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,14777,0)
 ;;=780.96^^90^866^17
 ;;^UTILITY(U,$J,358.3,14777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14777,1,4,0)
 ;;=4^780.96
 ;;^UTILITY(U,$J,358.3,14777,1,5,0)
 ;;=5^Generalized Pain
 ;;^UTILITY(U,$J,358.3,14777,2)
 ;;=^334163
 ;;^UTILITY(U,$J,358.3,14778,0)
 ;;=607.9^^90^866^30
 ;;^UTILITY(U,$J,358.3,14778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14778,1,4,0)
 ;;=4^607.9
 ;;^UTILITY(U,$J,358.3,14778,1,5,0)
 ;;=5^Penile Pain
 ;;^UTILITY(U,$J,358.3,14778,2)
 ;;=^270442
 ;;^UTILITY(U,$J,358.3,14779,0)
 ;;=608.9^^90^866^32
 ;;^UTILITY(U,$J,358.3,14779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14779,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,14779,1,5,0)
 ;;=5^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,14779,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,14780,0)
 ;;=V68.1^^90^867^4
 ;;^UTILITY(U,$J,358.3,14780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14780,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,14780,1,5,0)
 ;;=5^Rx Refill (Also mark Condition)
 ;;^UTILITY(U,$J,358.3,14780,2)
 ;;=RX Refill (also mark Condition)^295585
 ;;^UTILITY(U,$J,358.3,14781,0)
 ;;=V68.81^^90^867^6
 ;;^UTILITY(U,$J,358.3,14781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14781,1,4,0)
 ;;=4^V68.81
 ;;^UTILITY(U,$J,358.3,14781,1,5,0)
 ;;=5^Transfer of Care (Also Mark Dx)
 ;;^UTILITY(U,$J,358.3,14781,2)
 ;;=Transfer of Care ^295587
 ;;^UTILITY(U,$J,358.3,14782,0)
 ;;=V58.83^^90^867^5
 ;;^UTILITY(U,$J,358.3,14782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14782,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,14782,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,14782,2)
 ;;=Encounter for Therapeutic Drug Monitoring^322076
 ;;^UTILITY(U,$J,358.3,14783,0)
 ;;=V65.19^^90^867^3
 ;;^UTILITY(U,$J,358.3,14783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14783,1,4,0)
 ;;=4^V65.19
 ;;^UTILITY(U,$J,358.3,14783,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,14783,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,14784,0)
 ;;=V60.89^^90^867^1
 ;;^UTILITY(U,$J,358.3,14784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14784,1,4,0)
 ;;=4^V60.89
 ;;^UTILITY(U,$J,358.3,14784,1,5,0)
 ;;=5^Housing/Economic Circumstances
 ;;^UTILITY(U,$J,358.3,14784,2)
 ;;=^295545
 ;;^UTILITY(U,$J,358.3,14785,0)
 ;;=V68.09^^90^867^2
 ;;^UTILITY(U,$J,358.3,14785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14785,1,4,0)
 ;;=4^V68.09
